title: Cell-specific mRNA alterations in Na+, K+-ATPase α and β isoforms and FXYD in mice treated chronically with carbamazepine, an anti-bipolar drug.
abstract: Evidence accumulating during almost 50 years suggests Na(+), K(+)-ATPase dysfunction in bipolar disorder, a disease treatable with chronic administration of lithium salts, carbamazepine or valproic acid. Three Na(+), K(+)-ATPase α subunits (α1-3) and two β subunits (β1 and β2) are expressed in brain together with the auxiliary protein FXYD7. FXYD7 decreases K(+) affinity, and thus contributes to stimulation of the enzyme at elevated extracellular K(+) concentrations. Na(+), K(+)-ATPase subtype and FXYD7 genes were determined by RT-PCR in mice co-expressing one fluorescent signal with an astrocytic marker or a different fluorescent signal with a neuronal marker and treated for 14 days with carbamazepine. Following fluorescence-activated cell sorting of neurons and astrocytes it was shown that α2 Expression was upregulated in astrocytes and neurons and α1 selectively in neurons, but α3 was unchanged. β1 was upregulated in astrocytes, but not in neurons. β2 was unaffected in astrocytes and absent in neurons. FXYD7 was downregulated specifically in neurons. According to cited literature data these changes should facilitate K(+) uptake in neurons, without compromising preferential uptake in astrocytes at increased extracellular K(+) concentrations. This process seems to be important for K(+) homeostasis of the cellular level of the brain (Xu et al. Neurochem Res E-pub Dec. 12, 2012).
authors: Department of Clinical Pharmacology, China Medical University, No 92 Beier Road, Heping District, Shenyang, People's Republic of China.
authors: Baoman
authors: B
authors: Li
authors: Leif
authors: L
authors: Hertz
authors: Liang
authors: L
authors: Peng
mesh_terms: D000818:Animals; D001253:Astrocytes / Q000187:drug effects / Q000201:enzymology*; D001714:Bipolar Disorder / Q000188:drug therapy; D002220:Carbamazepine / Q000494:pharmacology*; D005260:Female; D007527:Isoenzymes / Q000187:drug effects; D008297:Male; D008562:Membrane Glycoproteins / Q000096:biosynthesis*; D051379:Mice; D009419:Nerve Tissue Proteins / Q000096:biosynthesis*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000187:drug effects / Q000378:metabolism*
chemical_list: C462940:Fxyd7 protein, mouse; D007527:Isoenzymes; D008562:Membrane Glycoproteins; D009419:Nerve Tissue Proteins; D012333:RNA, Messenger; D002220:Carbamazepine; C497344:Atp1a1 protein, mouse; D000254:Sodium-Potassium-Exchanging ATPase
references: EMBO J. 2002 Jul 1;21(13):3264-73
references: 12093728
references: Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27;37(1):56-61
references: 22230647
references: Biol Psychiatry. 2009 Jun 1;65(11):985-91
references: 19058785
references: J Neurochem. 1989 Apr;52(4):1042-9
references: 2538559
references: Am J Med Genet. 2001 Apr 8;105(3):291-4
references: 11353452
references: Acta Psychiatr Scand. 2012 Nov;126(5):315-31
references: 22881296
references: Am J Physiol. 1994 Feb;266(2 Pt 2):F240-5
references: 8141325
references: J Neurosci. 1997 May 15;17(10):3488-502
references: 9133374
references: Nature. 1965 Jun 12;206(989):1091-4
references: 5325441
references: Neuron. 2000 Oct;28(1):41-51
references: 11086982
references: Physiol Res. 2006;55(3):325-38
references: 16083303
references: J Neurosci. 1991 Feb;11(2):381-91
references: 1846906
references: Glia. 2012 Apr;60(4):651-60
references: 22290828
references: Psychiatry Clin Neurosci. 2004 Feb;58(1):82-8
references: 14678462
references: Am J Physiol Regul Integr Comp Physiol. 2008 Nov;295(5):R1660-70
references: 18799636
references: Biol Psychiatry. 2006 Sep 1;60(5):491-9
references: 16712803
references: Brain Res Dev Brain Res. 1991 Nov 19;63(1-2):1-12
references: 1686423
references: Sci Signal. 2012 Apr 03;5(218):ra26
references: 22472648
references: Neurochem Res. 2012 Nov;37(11):2299-309
references: 22367475
references: Brain Res. 1983 Nov 21;279(1-2):65-76
references: 6315183
references: Brain Res Bull. 1996;40(3):167-74
references: 8736577
references: Leukemia. 2000 Dec;14(12):2118-27
references: 11187901
references: Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18144-9
references: 22025725
references: Br Med J. 1966 Jan 8;1(5479):71-5
references: 5902530
references: J Neurosci. 2008 Jan 2;28(1):264-78
references: 18171944
references: Proc Natl Acad Sci U S A. 1997 May 27;94(11):5943-8
references: 9159180
references: BMC Psychiatry. 2012 May 23;12:47
references: 22620289
references: Neurochem Res. 2012 Nov;37(11):2524-40
references: 22965852
references: Am J Physiol Regul Integr Comp Physiol. 2008 Apr;294(4):R1367-78
references: 18256141
references: Am J Physiol Regul Integr Comp Physiol. 2006 May;290(5):R1397-406
references: 16357096
references: J Neurosci Res. 1998 May 1;52(3):307-21
references: 9590439
references: J Affect Disord. 2010 Jun;123(1-3):303-7
references: 19880188
references: Bioorg Khim. 2003 Mar-Apr;29(2):146-58
references: 12708314
references: J Physiol. 2004 Mar 1;555(Pt 2):355-64
references: 14694143
references: J Neuroendocrinol. 2009 Feb;21(2):108-22
references: 19187398
references: Annu Rev Biochem. 2002;71:511-35
references: 12045105
references: Neurochem Int. 2010 Nov;57(4):411-20
references: 20380860
references: Neurochem Res. 2002 Feb;27(1-2):113-20
references: 11930908
references: Neurochem Int. 2012 Jul;61(2):187-94
references: 22564531
references: Neurochem Int. 2012 Dec;61(8):1325-32
references: 23017600
references: Brain Res. 1985 Jan 28;325(1-2):13-9
references: 2858247
references: Biol Psychiatry. 1998 Nov 1;44(9):892-7
references: 9807644
references: Biol Psychiatry. 1998 Jul 1;44(1):47-51
references: 9646882
references: Brain Res Mol Brain Res. 1994 Feb;21(3-4):333-43
references: 8170354
references: J Neurosci. 2007 Nov 7;27(45):12255-66
references: 17989291
references: J Bioenerg Biomembr. 1992 Jun;24(3):249-61
references: 1328174
references: Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(4-6):697-702
references: 6320304
references: Psychopharmacology (Berl). 1982;78(4):309-13
references: 6818589
references: Mol Biol Cell. 2004 Jul;15(7):3224-32
references: 15133131
references: J Biol Chem. 2000 Jan 21;275(3):1976-86
references: 10636900
references: Br Med J. 1966 Jul 30;2(5508):262-7
references: 5945554
references: Neurosci Lett. 2002 Aug 30;329(2):185-8
references: 12165408
references: Neurochem Int. 2000 Apr;36(4-5):291-300
references: 10732996
references: J Physiol. 1987 Jan;382:159-74
references: 2442359